Use of adjuvant chemotherapy and outcomes in women age 70 and older with HER2-positive (HER2+) or triple-negative (TN) breast cancer (BC)

被引：0
|
作者：
Hsu, Tina [1 ]
Speers, Caroline [1 ]
Tyldesley, Scott [1 ]
Chia, Stephen K. L. [1 ]
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1044
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Use of adjuvant chemotherapy and outcomes in women 70 years and older with HER-2 positive or triple negative breast cancer
    Hsu, T.
    Speers, C.
    Tyldesley, S.
    Mcgahan, C.
    Chia, S. K.
    CANCER RESEARCH, 2013, 73
  • [2] Neoadjuvant chemotherapy in HER2-positive and triple-negative breast cancer
    Goncalves, Anthony
    BULLETIN DU CANCER, 2016, 103 (06) : S76 - S89
  • [3] Correlation between TILs, ALDH1 and PD-L1 expression in triple-negative (TN) and HER2-positive (HER2+) breast cancer (BC)
    Lopez Flores, M.
    Honrado Franco, E.
    Sanchez Couisido, F.
    Minguito Carazo, C.
    Vallejo Pascual, M. E.
    Sanz Guadarrama, O.
    Garcia Palomo, A.
    Molina de la Torre, A. J.
    Lopez Gonzalez, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S437 - S438
  • [4] Neoadjuvant and Adjuvant Chemotherapy Treatment Patterns Among Older Triple-negative and HER2-positive Breast Cancer Patients with Comorbidities
    Tamirisa, Nina
    Dong, Wenli
    Shen, Yu
    Shaitelman, Simona
    Babiera, Gildy
    Bedrosian, Isabelle
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S315 - S316
  • [5] The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer
    Leon-Ferre, Roberto A.
    Hieken, Tina J.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (04) : 2111 - 2119
  • [6] Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer
    Tamirisa, Nina
    Dong, Wenli
    Shen, Yu
    Lin, Heather
    Shaitelman, Simona F.
    Babiera, Gildy
    Bedrosian, Isabelle
    NPJ BREAST CANCER, 2025, 11 (01)
  • [7] The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer
    Roberto A. Leon-Ferre
    Tina J. Hieken
    Judy C. Boughey
    Annals of Surgical Oncology, 2021, 28 : 2111 - 2119
  • [8] Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatment
    Houvenaeghel, Gilles
    Cohen, Monique
    Goncalves, Anthony
    Berthelot, Axel
    Chauvet, Marie Pierre
    Faure, Christelle
    Classe, Jean Marc
    Jouve, Eva
    Sabiani, Laura
    Bannier, Marie
    Tassy, Louis
    Martino, Marc
    Tallet, Agnes
    de Nonneville, Alexandre
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Sequencing of chemotherapy and surgery among older triple-negative and HER2-positive breast cancer patients with comorbidities
    Dharanikota, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1482 - S1482
  • [10] Neoadjuvant chemotherapy for triple-negative and HER2-positive breast cancer: Striving for the standard of care
    Roberts, Amanda
    Coburn, Natalie
    Wright, Frances
    Nguyen, Lena
    Gandhi, Sonal
    Hallet, Julie
    Jerzak, Katarzyna
    Eisen, Andrea
    Wilton, Andrew
    Hong, Nicole Look
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 199 - 200
12345